Designs and develops protection solutions for various industries and healthcare. Manufactures surgical gloves, single-use, and examination gloves for medical use. Now — the numbers.
This is an established company with proven profits.
No real growth (2% a year).
The gap is $507.1M. In times of high interest rates, a gap like that can squeeze a company.
The market pays 18.1× for every dollar of annual profit — around what a business like this usually costs.
No analyst target is on record for this company.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
It pays out $2.19 per share each year — regular cash for whoever holds the stock.
Over the last 4 years, sales grew only 2% a year on average. At this size, speeding back up is not easy.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: the revenue breakdown.